VRTX Stock Recent News
VRTX LATEST HEADLINES
The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $503.20, representing a -1.37% change from its previous close.
Instead of blindly buying during a selloff, Jeremy Mullin offers a four-step plan for 2025 to help investors pinpoint stocks and industries that will lead the next leg higher. Learn how to develop a disciplined strategy to capitalize on the market's abundant opportunities.
Biotech stocks are among the few industry groups producing breakouts and buyable stocks in an uncertain market. Vertex stock is among top biotechs to watch.
In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $512.52, indicating a +0.06% shift from the previous trading day.
Equity markets started 2025 pretty well, but things haven't been so rosy in the past couple of months. The tech-heavy Nasdaq Composite index is down by 8% since the beginning of the year as I write this.
Those who already own VRTX stock may retain it for some time to see if its CF sales continue to rise and how the Journavx and Alyftrek launch progress.
Are you reluctant to invest in stocks right now? That's understandable.
Many investors view the healthcare sector as a safe haven when the stock market is turbulent. That's understandable.
Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $502.92, signifying a +1.51% move from its prior day's close.
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Gilead Sciences (GILD) or Vertex Pharmaceuticals (VRTX). But which of these two stocks presents investors with the better value opportunity right now?